| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $60.8M | — | +31.1% |
| SG&A Expense | $22.0M | — | +31.4% |
| Operating Income | -$82.8M | — | -31.2% |
| Pre-tax Income | -$74.0M | — | -34.0% |
| Income Tax | $79K | — | -4.8% |
| Net Income | -$74.1M | — | -33.9% |
| EPS (Basic) | -$1.06 | — | -11.6% |
| EPS (Diluted) | -$1.06 | — | -11.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $451.8M | +243.4% | +322.6% |
| Short-term Investments | $608.1M | +1.6% | +49.6% |
| Current Assets | $1.07B | +44.8% | +105.9% |
| Total Assets | $1.29B | +38.0% | +81.1% |
| Current Liabilities | $33.0M | +18.1% | -0.0% |
| Total Liabilities | $37.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.6M | — | -14.6% |
| Capital Expenditures | $4.3M | — | +0.0% |
| Investing Cash Flow | -$35.3M | — | -372.3% |
| Financing Cash Flow | $411.2M | — | — |
| Free Cash Flow | -$59.9M | — | -13.4% |
| -7.2% |
| Stockholders' Equity | $1.26B | +38.9% | +86.5% |